Exchange Announcement • 27 Sep 2025 04:30
Exchange Announcement • 13 Sep 2025 04:27
Exchange Announcement • 09 Sep 2025 04:05
Exchange Announcement • 30 Aug 2025 04:30
Exchange Announcement • 16 Aug 2025 04:30
Search or
𝛼SK
𝛼SKENTITY
Adaptimmune Therapeutics (ADAP US)
Adaptimmune Therapeutics (ADAP US)
5
Analysis
Health Care • United States
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company develops novel cancer immunotherapy products based on T-cell receptor platform that helps to identify cancer targets. Adaptimmune Therapeutics serves customers worldwide.
morex